Peer-reviewedCC BYRheumatology advances in practice
With changes to NHS England commissioning policies for drugs used in rheumatology, is the role of the specialist commissioning multidisciplinary team obsolete?
- 1Department of Rheumatology, NHS University Hospitals of Liverpool Group, Liverpool, United Kingdom.
Related
- The 2026 British Society for Rheumatology guideline for the treatment of polymyalgia rheumatica
- Diagnostic Yield of Internal Medicine Referrals to Rheumatology: A Retrospective Single-Center Study
- Real‐World Use of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Early and Long‐Term Clinical, Renal, and Patient‐Reported Outcomes in an Italian Rheumatology–Nephrology Network
- From implicit assumptions to explicit ethics: assessment of normative frameworks in digitalization recommendations in rheumatology
- 'Let's work alongside it': healthcare professionals' perspectives of generative AI in supporting care at home in paediatric rheumatology.
BibTeX
@article{syrimi2026with,
title = {{With changes to NHS England commissioning policies for drugs used in rheumatology, is the role of the specialist commissioning multidisciplinary team obsolete?}},
author = {Zoe Syrimi and Zoe McLaren and Robert J Moots and Devesh Mewar and Rosalind Benson},
journal = {Rheumatology advances in practice},
year = {2026},
month = oct,
doi = {10.1093/rap/rkag139},
url = {https://europepmc.org/article/MED/42999705},
note = {CC BY},
}
RIS
TY - JOUR
TI - With changes to NHS England commissioning policies for drugs used in rheumatology, is the role of the specialist commissioning multidisciplinary team obsolete?
AU - Zoe Syrimi
AU - Zoe McLaren
AU - Robert J Moots
AU - Devesh Mewar
AU - Rosalind Benson
PY - 2026
DA - 2026/10/30
JO - Rheumatology advances in practice
DO - 10.1093/rap/rkag139
UR - https://europepmc.org/article/MED/42999705
SN - 2514-1775
ER -